HealthEquity/$HQY
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About HealthEquity
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Ticker
$HQY
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
3,113
ISIN
US42226A1079
Website
HealthEquity Metrics
BasicAdvanced
$8.8B
74.64
$1.37
0.49
-
Price and volume
Market cap
$8.8B
Beta
0.49
52-week high
$116.65
52-week low
$65.01
Average daily volume
1.2M
Financial strength
Current ratio
4.064
Quick ratio
3.474
Long term debt to equity
51.643
Total debt to equity
52.112
Interest coverage (TTM)
3.82%
Profitability
EBITDA (TTM)
405.703
Gross margin (TTM)
65.52%
Net profit margin (TTM)
9.80%
Operating margin (TTM)
19.59%
Effective tax rate (TTM)
20.78%
Revenue per employee (TTM)
$400,000
Management effectiveness
Return on assets (TTM)
4.57%
Return on equity (TTM)
5.77%
Valuation
Price to earnings (TTM)
74.641
Price to revenue (TTM)
7.143
Price to book
4.17
Price to tangible book (TTM)
-12.59
Price to free cash flow (TTM)
101.457
Free cash flow yield (TTM)
0.99%
Free cash flow per share (TTM)
100.69%
Growth
Revenue change (TTM)
19.21%
Earnings per share change (TTM)
48.80%
3-year revenue growth (CAGR)
16.90%
10-year revenue growth (CAGR)
28.99%
3-year earnings per share growth (CAGR)
27.47%
10-year earnings per share growth (CAGR)
19.61%
What the Analysts think about HealthEquity
Analyst ratings (Buy, Hold, Sell) for HealthEquity stock.
Bulls say / Bears say
HealthEquity reported a 19% year-over-year increase in Q4 fiscal 2025 revenues, reaching $311.8 million, driven by growth across service, custodial, and interchange revenue streams. (Benzinga)
The company experienced a 14% year-over-year increase in Health Savings Accounts (HSAs), totaling 9.9 million as of January 31, 2025, with total HSA assets rising 27% to $32.1 billion. (Benzinga)
Analysts have maintained a positive outlook, with an average 12-month price target of $112.5, indicating potential for stock appreciation. (Benzinga)
In Q4 fiscal 2025, HealthEquity's adjusted earnings per share were $0.69, missing analyst estimates of $0.72, leading to a significant stock decline. (Benzinga)
The company faced increased operational costs due to rising cyber threats and fraud-related expenses, impacting profitability. (TradingView News)
HealthEquity's stock has declined over 13% year-to-date as of June 2025, underperforming the broader market and raising concerns about investor confidence. (TradingView News)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.
HealthEquity Financial Performance
Revenues and expenses
HealthEquity Earnings Performance
Company profitability
HealthEquity News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for HealthEquity stock?
HealthEquity (HQY) has a market cap of $8.8B as of July 05, 2025.
What is the P/E ratio for HealthEquity stock?
The price to earnings (P/E) ratio for HealthEquity (HQY) stock is 74.64 as of July 05, 2025.
Does HealthEquity stock pay dividends?
No, HealthEquity (HQY) stock does not pay dividends to its shareholders as of July 05, 2025.
When is the next HealthEquity dividend payment date?
HealthEquity (HQY) stock does not pay dividends to its shareholders.
What is the beta indicator for HealthEquity?
HealthEquity (HQY) has a beta rating of 0.49. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.